Your browser doesn't support javascript.
loading
Activation of activin/Smad2 and 3 signaling pathway and the potential involvement of endothelial­mesenchymal transition in the valvular damage due to rheumatic heart disease.
Xian, Shenglin; Chen, Ang; Wu, Xiaodan; Lu, Chuanghong; Wu, Yunjiao; Huang, Feng; Zeng, Zhiyu.
Affiliation
  • Xian S; Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
  • Chen A; Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
  • Wu X; Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
  • Lu C; Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
  • Wu Y; Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
  • Huang F; Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
  • Zeng Z; Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Mol Med Rep ; 23(1)2021 01.
Article in En | MEDLINE | ID: mdl-33179113

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rheumatic Heart Disease / Activins / Smad2 Protein / Smad3 Protein / Mitral Valve Type of study: Etiology_studies / Prognostic_studies Limits: Animals Language: En Journal: Mol Med Rep Year: 2021 Document type: Article Country of publication: Greece

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rheumatic Heart Disease / Activins / Smad2 Protein / Smad3 Protein / Mitral Valve Type of study: Etiology_studies / Prognostic_studies Limits: Animals Language: En Journal: Mol Med Rep Year: 2021 Document type: Article Country of publication: Greece